These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9357251)
21. Advances in cervical screening technology. Stoler MH Mod Pathol; 2000 Mar; 13(3):275-84. PubMed ID: 10757338 [TBL] [Abstract][Full Text] [Related]
22. Stop cervical cancer in its tracks. Bence SA Nurse Pract; 2000 Apr; 25(4):16-7. PubMed ID: 10790794 [No Abstract] [Full Text] [Related]
23. [Prevention of cervical cancer. Screening and vaccination: methods of use]. Boulanger JC Gynecol Obstet Fertil; 2011; 39(7-8):405-6. PubMed ID: 21757389 [No Abstract] [Full Text] [Related]
24. Primary screening for human papillomavirus infection. Dillner J Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):743-57. PubMed ID: 11563870 [TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus. To screen or not to screen. Newkirk GR Arch Fam Med; 1993 Dec; 2(12):1227-8. PubMed ID: 8130902 [No Abstract] [Full Text] [Related]
28. Innovative approaches to cervical cancer prevention. Blumenthal PD; Ringers P; McIntosh N; Gaffikin L Medscape Womens Health; 2001 Dec; 6(6):1. PubMed ID: 11965215 [No Abstract] [Full Text] [Related]
29. [Oral contraceptive and the increased risk of cervical cancer]. Heikinheimo O; Leminen A Duodecim; 2003; 119(24):2405-6. PubMed ID: 14870500 [No Abstract] [Full Text] [Related]
30. Primary and secondary prevention of cervical cancer--opportunities and challenges. Markowitz LE; Unger ER; Saraiya M J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638 [No Abstract] [Full Text] [Related]
31. [Testing for human papillomavirus in cervical cancer screening]. Kjaer SK Ugeskr Laeger; 2002 Jan; 164(2):173-5. PubMed ID: 11831083 [No Abstract] [Full Text] [Related]
32. A human papillomavirus type 16 vaccine. Yoo SS; Whitmore SE N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12678023 [No Abstract] [Full Text] [Related]
33. Assessing the HPV vaccine: researchers confront complex interplay of factors. Tuma RS J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636 [No Abstract] [Full Text] [Related]
34. Mathematical model of HPV provides insight into impacts of risk factors and vaccine. Kim JJ PLoS Med; 2006 May; 3(5):e164. PubMed ID: 16573363 [TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. Wang SS; Hildesheim A; Gao X; Schiffman M; Herrero R; Bratti MC; Sherman ME; Barnes WA; Greenberg MD; McGowan L; Mortel R; Schwartz PE; Zaino RJ; Glass AG; Burk RD; Karacki P; Carrington M Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):419-20. PubMed ID: 11927505 [No Abstract] [Full Text] [Related]
36. [Population-based study of human papillomavirus infection in high-risk area for cervical cancer in Shanxi Province, China]. Shen YH; Chen F; Huang MN; Liu B; Wang XX; Zhao FH; Li SM; Li N; Wu LY; Rong SD; Zhang WH; Ren SD; Huang RD; Qiao YL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):381-5. PubMed ID: 12974078 [TBL] [Abstract][Full Text] [Related]
37. HPV vaccine trial may take place in India. Sharma DC Lancet Oncol; 2002 Nov; 3(11):649. PubMed ID: 12424057 [No Abstract] [Full Text] [Related]
38. Role of human papilloma virus testing in cervical cancer prevention. Fey MC; Beal MW J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135 [TBL] [Abstract][Full Text] [Related]